281 related articles for article (PubMed ID: 33316375)
1. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy.
Yang C; Zhang J; Liao M; Yang Y; Wang Y; Yuan Y; Ouyang L
Drug Discov Today; 2021 Mar; 26(3):817-825. PubMed ID: 33316375
[TBL] [Abstract][Full Text] [Related]
2. Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).
Lee LC; Peng YH; Chang HH; Hsu T; Lu CT; Huang CH; Hsueh CC; Kung FC; Kuo CC; Jiaang WT; Wu SY
J Med Chem; 2021 Aug; 64(15):11288-11301. PubMed ID: 34337952
[TBL] [Abstract][Full Text] [Related]
3. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial translation requires folate-dependent tRNA methylation.
Morscher RJ; Ducker GS; Li SH; Mayer JA; Gitai Z; Sperl W; Rabinowitz JD
Nature; 2018 Feb; 554(7690):128-132. PubMed ID: 29364879
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.
Ju HQ; Lu YX; Chen DL; Zuo ZX; Liu ZX; Wu QN; Mo HY; Wang ZX; Wang DS; Pu HY; Zeng ZL; Li B; Xie D; Huang P; Hung MC; Chiao PJ; Xu RH
J Natl Cancer Inst; 2019 Jun; 111(6):584-596. PubMed ID: 30534944
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.
Dekhne AS; Hou Z; Gangjee A; Matherly LH
Mol Cancer Ther; 2020 Nov; 19(11):2245-2255. PubMed ID: 32879053
[TBL] [Abstract][Full Text] [Related]
7. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review).
Konno M; Asai A; Kawamoto K; Nishida N; Satoh T; Doki Y; Mori M; Ishii H
Int J Oncol; 2017 Apr; 50(4):1057-1063. PubMed ID: 28259896
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
Nishimura T; Nakata A; Chen X; Nishi K; Meguro-Horike M; Sasaki S; Kita K; Horike SI; Saitoh K; Kato K; Igarashi K; Murayama T; Kohno S; Takahashi C; Mukaida N; Yano S; Soga T; Tojo A; Gotoh N
Oncogene; 2019 Apr; 38(14):2464-2481. PubMed ID: 30532069
[TBL] [Abstract][Full Text] [Related]
9. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
[TBL] [Abstract][Full Text] [Related]
10. Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism.
Zhang F; Wang D; Li J; Su Y; Liu S; Lei QY; Yin M
J Mol Cell Biol; 2022 Jul; 14(4):. PubMed ID: 35349697
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.
Tedeschi PM; Vazquez A; Kerrigan JE; Bertino JR
Mol Cancer Res; 2015 Oct; 13(10):1361-6. PubMed ID: 26101208
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.
Cheung CHY; Hsu CL; Tsuei CY; Kuo TT; Huang CT; Hsu WM; Chung YH; Wu HY; Hsu CC; Huang HC; Juan HF
Cell Death Dis; 2019 Oct; 10(11):786. PubMed ID: 31624245
[TBL] [Abstract][Full Text] [Related]
13. The importance of mitochondrial folate enzymes in human colorectal cancer.
Miyo M; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Tsunekuni K; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H
Oncol Rep; 2017 Jan; 37(1):417-425. PubMed ID: 27878282
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
Nilsson R; Nicolaidou V; Koufaris C
Gene; 2019 Oct; 716():144032. PubMed ID: 31377316
[TBL] [Abstract][Full Text] [Related]
15. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
[TBL] [Abstract][Full Text] [Related]
16. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
Li G; Wu J; Li L; Jiang P
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell.
Wan X; Wang C; Huang Z; Zhou D; Xiang S; Qi Q; Chen X; Arbely E; Liu CY; Du P; Yu W
Cell Death Dis; 2020 Aug; 11(8):649. PubMed ID: 32811824
[TBL] [Abstract][Full Text] [Related]
18. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.
Wang LW; Shen H; Nobre L; Ersing I; Paulo JA; Trudeau S; Wang Z; Smith NA; Ma Y; Reinstadler B; Nomburg J; Sommermann T; Cahir-McFarland E; Gygi SP; Mootha VK; Weekes MP; Gewurz BE
Cell Metab; 2019 Sep; 30(3):539-555.e11. PubMed ID: 31257153
[TBL] [Abstract][Full Text] [Related]
20. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.
Zhu Z; Kiang KM; Li N; Liu J; Zhang P; Jin L; He X; Zhang S; Leung GK
Cancer Lett; 2022 Nov; 549():215903. PubMed ID: 36089117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]